GOLDMAN SACHS GROUP INC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q2 2024$6,915,818
+6.0%
1,094,275
-10.0%
0.00%0.0%
Q1 2024$6,526,596
+0.8%
1,215,381
-5.8%
0.00%0.0%
Q4 2023$6,476,493
+795.9%
1,290,138
+201.6%
0.00%
Q3 2023$722,921
-4.8%
427,764
+56.6%
0.00%
Q2 2023$759,274
+18.0%
273,120
-22.8%
0.00%
Q1 2023$643,481
-89.0%
353,561
-69.3%
0.00%
-100.0%
Q4 2022$5,839,240
+207554.3%
1,151,724
+103.5%
0.00%0.0%
Q3 2022$2,812
+32.4%
565,843
-0.9%
0.00%0.0%
Q2 2022$2,124
-99.9%
570,840
+39.9%
0.00%
Q1 2022$2,290,000
+43.9%
408,175
+56.0%
0.00%
Q4 2021$1,591,000
-27.6%
261,699
+15.9%
0.00%
Q3 2021$2,199,000
-21.6%
225,747
+14.9%
0.00%
-100.0%
Q2 2021$2,804,000
+45.6%
196,407
+142.1%
0.00%
Q1 2021$1,926,00081,1420.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$3,857,0000.50%
ORACLE INVESTMENT MANAGEMENT INC 400,013$2,244,0000.44%
HARBOURVEST PARTNERS LLC 335,709$1,883,0000.38%
Winning Points Advisors, LLC 60,126$339,0000.26%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$541,0000.19%
SHEETS SMITH WEALTH MANAGEMENT 203,876$1,144,0000.16%
Delphia (USA) Inc. 25,504$143,0000.11%
Clearwater Capital Advisors, LLC 147,891$830,0000.10%
Corton Capital Inc. 36,843$207,0000.09%
Virtus ETF Advisers LLC 27,343$153,0000.07%
View complete list of IMMUNITYBIO INC shareholders